Uncovering a tumor suppressor for triple-negative breast cancers.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 21376226.
- Also identified by DOI 10.1016/j.cell.2011.02.030.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
"Triple-negative" breast cancers are aggressive malignancies that respond poorly to treatments. Now Sun et al. (2011) find that the activity of the protein tyrosine phosphatase PTPN12 is lost in a large percentage of this breast cancer subtype, offering molecular drivers and possible therapeutic targets for this heterogeneous and intractable cancer.